Craneware (LON:CRW) Stock Price Passes Above 200 Day Moving Average - Here's Why

Key Points

• Craneware plc stock price recently crossed above its 200-day moving average, trading at GBX 2,200 ($29.66) after reaching a high of GBX 2,250 ($30.34).
• Analysts maintain a consensus "Buy" rating for Craneware, with a target price averaging GBX 2,725 based on recent reports from Berenberg Bank and Shore Capital.
• The company has a market capitalization of £939.68 million and a relatively high PE ratio of 80.80, indicating strong growth expectations.

Shares of Craneware plc (LON:CRW - Get Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,997.76 ($26.97) and traded as high as GBX 2,250 ($30.38). Craneware shares last traded at GBX 2,200 ($29.71), with a volume of 80,424 shares changing hands.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on CRW. Shore Capital reissued a "buy" rating and issued a GBX 2,650 target price on shares of Craneware in a report on Wednesday, July 16th. Berenberg Bank began coverage on shares of Craneware in a report on Wednesday, July 16th. They issued a "buy" rating and a GBX 2,800 target price for the company. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of GBX 2,725.

Craneware Stock Performance

The firm has a market capitalization of £759.54 million, a P/E ratio of 5,047.06 and a beta of 0.28. The firm has a 50-day moving average price of GBX 2,264.87 and a two-hundred day moving average price of GBX 2,002.45. The company has a debt-to-equity ratio of 12.22, a current ratio of 0.63 and a quick ratio of 1.00.

About Craneware

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.